SUSTAINED-RELEASE MECHANISMS OF WAX MATRIX SYSTEM FOR CONTROLLED-RELEASE

被引:0
|
作者
KATO, Y [1 ]
SUNADA, H [1 ]
YONEZAWA, Y [1 ]
ISHINO, R [1 ]
机构
[1] TANABE SEIYAKU CO LTD, PHARMACEUT RES LAB, YODOGAWA KU, OSAKA 532, JAPAN
关键词
WAX MATRIX; SUSTAINED RELEASE; RESERVOIR DEVICE; PARTICLE SIZE; TORTUOSITY; VISCOSITY;
D O I
暂无
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
In order to elucidate the influence of the particle size of water-soluble ingredients in a wax matrix and the solubility of drugs on the drug dissolution rate from a dosage form, reservoir devices were prepared from a wax matrix layer consisting of hydrogenated easter oil (HCO) and lactose, a drug reservoir and a water non-permeable layer of HCO, and dissolution tests were then carried out. Drug permeability and water penetrability of the wax matrix layer were affected by the particle size of lactose incorporated into the wax matrix layer. Drug permeability and water penetrability could be decreased by using smaller lactose particles. Tortuosity in the wax matrix layer after the dissolution of lactose could be increased inversely proportional to the particle size. Permeability of the wax matrix layer differed depending on the kinds of drugs forming the drug reservoir, which was attributed to differences in the solubility and viscosity of the drug saturated solution formed in the drug reservoir.
引用
收藏
页码:1646 / 1650
页数:5
相关论文
共 50 条
  • [1] Oilfield sustained-release tracers based on different binding forms and their controlled-release mechanism
    Wang, Chen
    Li, Xuhong
    Cheng, Xiaoliang
    Chen, Zhigang
    Wang, Tao
    Zhang, Xing
    Dong, Xiaoyu
    Yang, Xiaowu
    Dai, Fangfang
    Zhang, Kang
    [J]. GEOENERGY SCIENCE AND ENGINEERING, 2024, 232
  • [2] CHARACTERIZATION OF COMMERCIALLY AVAILABLE THEOPHYLLINE SUSTAINED-RELEASE OR CONTROLLED-RELEASE SYSTEMS - INVITRO DRUG RELEASE PROFILES
    PO, ALW
    WONG, LP
    GILLIGAN, CA
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1990, 66 (1-3) : 111 - 130
  • [3] NIACIN REVISITED - A RANDOMIZED, CONTROLLED TRIAL OF WAX-MATRIX SUSTAINED-RELEASE NIACIN IN HYPERCHOLESTEROLEMIA
    KEENAN, JM
    FONTAINE, PL
    WENZ, JB
    MYERS, S
    HUANG, ZQ
    RIPSIN, CM
    [J]. ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (07) : 1424 - 1432
  • [4] Controlled-release of diclofenac sodium from wax matrix granule
    Miyagawa, Y
    Okabe, T
    Yamaguchi, Y
    Miyajima, M
    Sato, H
    Sunada, H
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1996, 138 (02) : 215 - 224
  • [5] COMPARISON OF THE INVITRO RELEASE CHARACTERISTICS OF A WAX MATRIX AND A HYDROGEL SUSTAINED-RELEASE DICLOFENAC SODIUM TABLET
    BAIN, JC
    TAN, SB
    GANDERTON, D
    SOLOMON, MC
    [J]. DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1991, 17 (02) : 215 - 232
  • [6] RELEASE MECHANISMS IN GELFORMING SUSTAINED-RELEASE PREPARATIONS
    BAMBA, M
    PUISIEUX, F
    MARTY, JP
    CARSTENSEN, JT
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1979, 2 (5-6) : 307 - 315
  • [7] POLYMER MATRIX SYSTEM WITH SUSTAINED-RELEASE - APPLICATION TO MALARIA
    TSAKALA, M
    VERT, M
    LEGRAS, R
    GILLARD, J
    [J]. 5TH INTERNATIONAL CONFERENCE ON PHARMACEUTICAL TECHNOLOGY, VOLS 1-5, 1989, : A307 - A316
  • [8] SUSTAINED-RELEASE ANTIPARKINSON AGENTS - CONTROLLED RELEASE LEVODOPA
    GAUTHIER, S
    AMYOT, D
    [J]. CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1992, 19 (01) : 153 - 155
  • [9] SUSTAINED-RELEASE PLASTIC MATRIX TABLETS
    ROWE, RC
    [J]. MANUFACTURING CHEMIST AND AEROSOL NEWS, 1975, 46 (03) : 23 - 26
  • [10] POLYCARBOPHIL AS A CONTROLLED-RELEASE MATRIX
    HOSNY, EA
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1993, 98 (1-3) : 235 - 238